Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.
Fewer than 30% of health system leaders said they earned significant return on investment from virtual care offerings, ...
Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...
The hospital operator will invest more in organic hospital growth and high-acuity service lines as it sees strong demand for ...
Dr. Cliff Deveny announced the transition less than a month after General Catalyst finalized its $515 million acquisition of ...
The partnership with Noom aims to cut costs by treating weight management as preventative healthcare. Nearly 2 million ...
Overall, Cigna expects earnings to grow next year after posting a solid third quarter. But investments in a new PBM model and ...
The goodwill impairment charge is meant to realign Centene’s value on its own books with it value in the market, which has ...
The new portal is built using foundation models from OpenAI, the maker of popular AI chatbot ChatGPT, Oracle said in a press release. The tool could be used to describe medical jargon, like explaining ...
The healthcare giant beat Wall Street expectations in the third quarter, but reported a net loss after recording a $5.7 ...
The operator increased its outlook after posting earnings growth in the third quarter, aided by strong demand for services in ...
Measuring financial returns from AI can be challenging, experts said at the HLTH conference last week. But other metrics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results